SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime

被引:36
|
作者
Domingues, Renato [1 ]
Lippi, Alice [1 ,2 ]
Setz, Cristian [1 ,5 ]
Outeiro, Tiago F. [1 ,3 ,4 ]
Krisko, Anita [1 ]
机构
[1] Univ Med Ctr Goettingen, Ctr Biostruct Imaging Neurodegenerat, Dept Expt Neurodegenerat, Gottingen, Germany
[2] Univ Split, Fac Sci, Ctr Excellence Sci & Technol Integrat Mediterrane, Split, Croatia
[3] Max Planck Inst Expt Med, Gottingen, Germany
[4] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England
[5] Univ Med Ctr Goettingen, Dept Otolaryngol Head & Neck Surg, Gottingen, Germany
来源
AGING-US | 2020年 / 12卷 / 18期
关键词
aging; SARS-CoV-2; COVID-19; neuroinflammation; inflammaging; immunosenescence; CLINICAL CHARACTERISTICS; FUNCTIONAL RECEPTOR; INFLUENZA-VIRUS; AGE; CELL; CORONAVIRUS; INFECTION; SARS; DISEASE; SENESCENCE;
D O I
10.18632/aging.103989
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pneumonia outbreak in the city of Wuhan, China, prompted the finding of a novel strain of severe acute respiratory syndrome virus (SARS-CoV-2). Here, we discuss potential long-term consequences of SARS-CoV-2 infection, and its possibility to cause permanent damage to the immune system and the central nervous system. Advanced chronological age is one of the main risk factors for the adverse outcomes of COVID-19, presumably due to immunosenescence and chronic low-grade inflammation, both characteristic of the elderly. The combination of viral infection and chronic inflammation in advanced chronological age might cause multiple detrimental unforeseen consequences for the predisposition and severity of neurodegenerative diseases and needs to be considered so that we can be prepared to deal with future outcomes of the ongoing pandemic.
引用
收藏
页码:18778 / 18789
页数:12
相关论文
共 50 条
  • [1] Immunosenescence and Inflammaging in COVID-19
    Asghari, Faezeh
    Asghary, Amir
    Zolbanin, Naime Majidi
    Faraji, Fatemeh
    Jafari, Reza
    [J]. VIRAL IMMUNOLOGY, 2023, 36 (09) : 579 - 592
  • [2] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [3] Focus on SARS-CoV-2 and COVID-19
    Chen, Sharon C-A.
    Rawlinson, William D.
    [J]. PATHOLOGY, 2020, 52 (07) : 743 - 744
  • [4] SARS-CoV-2 and the pandemic of COVID-19
    Adil, Md Tanveer
    Rahman, Rumana
    Whitelaw, Douglas
    Jain, Vigyan
    Al-Taan, Omer
    Rashid, Farhan
    Munasinghe, Aruna
    Jambulingam, Periyathambi
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1144) : 110 - 116
  • [5] Characteristics of SARS-CoV-2 and COVID-19
    Ben Hu
    Hua Guo
    Peng Zhou
    Zheng-Li Shi
    [J]. Nature Reviews Microbiology, 2021, 19 : 141 - 154
  • [6] Coronavirus, COVID-19 and SARS-CoV-2
    Megias, Jorge
    [J]. REVISTA HISPANOAMERICANA DE HERNIA, 2020, 8 (02) : 111 - 111
  • [7] Characteristics of SARS-CoV-2 and COVID-19
    Hu, Ben
    Guo, Hua
    Zhou, Peng
    Shi, Zheng-Li
    [J]. NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) : 141 - 154
  • [8] SARS-CoV-2, COVID-19, and the Eye
    Cunningham, Emmett T.
    Zierhut, Manfred
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (04) : 629 - 630
  • [9] Delirium and SARS-CoV-2/COVID-19
    von Arnim, C.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
  • [10] Dementia and SARS-Cov-2/COVID-19
    Zieschang, T.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14